Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Those looking for a budget-friendly and convenient option
limited human data reveal no teratogenicity at therapeutic doses, yet clinicians are advised to employ the lowest effective regimen
The compound received FDA GRAS status for safety but was never approved as a drug because efficacy was insufficient for pharmaceutical registration
GHK-Cu collagen cross-linking and gene modulation require 4 to 8 weeks for visible results
However, neither compound is MHRA-approved for medical or therapeutic use in the UK
US$ 22.27
US$ 26.84
US$ 27.82
US$ 25.55
US$ 27.72
